157 related articles for article (PubMed ID: 30893175)
1. Squamous Cell Carcinoma In Situ With Occult Invasion: A Tertiary Care Institutional Experience.
Newsom E; Connolly K; Phillips W; Lee E; Rossi A; Navarrete-Dechent C; Busam K; Dusza SW; Nehal K
Dermatol Surg; 2019 Nov; 45(11):1345-1352. PubMed ID: 30893175
[TBL] [Abstract][Full Text] [Related]
2. Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery.
Chuang GS; Lu LK; Cummins DL; Wu H; Finn D; Rogers GS; Lee D
Dermatol Surg; 2012 Sep; 38(9):1456-60. PubMed ID: 22734860
[TBL] [Abstract][Full Text] [Related]
3. Squamous Cell Carcinoma In Situ Upstaged to Invasive Squamous Cell Carcinoma: A 5-Year, Single Institution Retrospective Review.
Eimpunth S; Goldenberg A; Hamman MS; Oganesyan G; Lee RA; Hunnangkul S; Song SS; Greywal T; Jiang SIB
Dermatol Surg; 2017 May; 43(5):698-703. PubMed ID: 28060173
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma in situ upstaging is not frequent in the nail unit: a tertiary cancer center experience.
Aleissa S; Cowen E; Navarrete-Dechent C; Busam KJ; Rossi AM; Lee EH; Nehal KS
Arch Dermatol Res; 2022 Jan; 314(1):89-93. PubMed ID: 32886149
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic assessment of depth of follicular invasion of squamous cell carcinoma (SCC) in situ (SCCis): Implications for treatment approach.
Christensen SR; McNiff JM; Cool AJ; Aasi SZ; Hanlon AM; Leffell DJ
J Am Acad Dermatol; 2016 Feb; 74(2):356-62. PubMed ID: 26670714
[TBL] [Abstract][Full Text] [Related]
6. Squamous Cell Carcinoma in Situ Achieves Tumor Clearance in More Mohs Stages Than Invasive Squamous Cell Carcinoma.
Kim Y; Khan AH; Papachristou C; Decker A; Lawrence N
Dermatol Surg; 2023 Dec; 49(12):1104-1107. PubMed ID: 38019009
[TBL] [Abstract][Full Text] [Related]
7. Frequency of squamous cell carcinoma (SCC) invasion in transected SCC in situ referred for Mohs surgery: the Dartmouth-Hitchcock experience.
Knackstedt TJ; Brennick JB; Perry AE; Li Z; Quatrano NA; Samie FH
Int J Dermatol; 2015 Jul; 54(7):830-3. PubMed ID: 25920731
[TBL] [Abstract][Full Text] [Related]
8. Rapid Evolution of a Squamous Cell Carcinoma In Situ to Locally Invasive With Perineural Involvement.
Juhasz M; Cohen JL
J Drugs Dermatol; 2020 Nov; 19(11):1110-1111. PubMed ID: 33196738
[TBL] [Abstract][Full Text] [Related]
9. Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ.
Queen D; Trager MH; Fan W; Gordon ER; Samie FH
Arch Dermatol Res; 2024 May; 316(6):220. PubMed ID: 38787403
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of squamous cell carcinoma in situ of the ear treated using Mohs micrographic surgery.
Lee KC; Higgins HW; Lajevardi N; Cruz AP; Dufresne RG
Dermatol Surg; 2012 Dec; 38(12):1951-5. PubMed ID: 22989104
[TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery of penile squamous cell carcinoma in situ with urethral extension.
Rismiller KP; Shahwan KT; Yu WY; Bordeaux JS; Carr DR
Arch Dermatol Res; 2022 Dec; 314(10):983-986. PubMed ID: 35031871
[TBL] [Abstract][Full Text] [Related]
12. Recurrence rates of cutaneous squamous cell carcinoma of the head and neck after Mohs micrographic surgery vs. standard excision: a retrospective cohort study.
van Lee CB; Roorda BM; Wakkee M; Voorham Q; Mooyaart AL; de Vijlder HC; Nijsten T; van den Bos RR
Br J Dermatol; 2019 Aug; 181(2):338-343. PubMed ID: 30199574
[TBL] [Abstract][Full Text] [Related]
13. Deep initial Mohs stage for scalp cutaneous squamous cell carcinoma to avoid occult tumor.
Lederhandler M; Stokar E; Meehan SA; Geronemus RG
J Am Acad Dermatol; 2020 Apr; 82(4):e129-e130. PubMed ID: 31836558
[No Abstract] [Full Text] [Related]
14. Application of Mohs micrographic surgery appropriate-use criteria to skin cancers at a university health system.
Blechman AB; Patterson JW; Russell MA
J Am Acad Dermatol; 2014 Jul; 71(1):29-35. PubMed ID: 24813300
[TBL] [Abstract][Full Text] [Related]
15. Factors Influencing Squamous Cell Carcinoma In Situ Recurrence and Implications for Treatment Choice.
Matsumoto AJ; Schmitt AR; Skelley LM; Baum CL
Dermatol Surg; 2018 May; 44(5):613-620. PubMed ID: 29112529
[TBL] [Abstract][Full Text] [Related]
16. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
[TBL] [Abstract][Full Text] [Related]
17. Squamous Cell Carcinoma in Situ: Review of Therapeutic Options with Emphasis on Treatment of Tumors of the Lower Extremity.
Vesely N; Beers P; Konda S; Motaparthi K
Skinmed; 2021; 19(4):257-265. PubMed ID: 34526198
[TBL] [Abstract][Full Text] [Related]
18. Low recurrence rates for challenging squamous cell carcinomas using Mohs micrographic surgery with AE1/AE3 cytokeratin immunostaining.
Aizman L; Miller CJ; Perz AM; Lukowiak TM; Cohen OG; Bean E; Hitchner MK; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; Cohen JV; Miura JT; Sobanko JF
J Am Acad Dermatol; 2021 May; 84(5):1453-1455. PubMed ID: 32622892
[No Abstract] [Full Text] [Related]
19. Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma.
Delgado Jiménez Y; Camarero-Mulas C; Sanmartín-Jiménez O; Garcés JR; Rodríguez-Prieto MÃ; Alonso-Alonso T; Miñano Medrano R; López-Estebaranz JL; de Eusebio Murillo E; Redondo P; Ciudad-Blanco C; Toll A; Artola Igarza JL; Allende Markixana I; Suarez Fernández R; Alfaro Rubio A; Alonso Pacheco ML; Vázquez-Veiga H; de la Cueva Dobao P; Ruiz-Salas V; Vilarrasa E; Barchino L; Morales-Gordillo V; Ocerin-Guerra I; Navarro Tejedor R; Hueso L; Mayor Arenal M; Seoane-Pose MJ; Cano-Martinez N; Garcia-Doval I; Descalzo MA;
Int J Dermatol; 2018 Nov; 57(11):1375-1381. PubMed ID: 30246444
[TBL] [Abstract][Full Text] [Related]
20. Reasons for Mohs Micrographic Surgery Cancellation: A Retrospective 1-Year Analysis in a Tertiary Care Clinic Before the COVID-19 Pandemic.
Nadimi AE; Spierling Bagsic SR; Prosser M; Greenway HT
Dermatol Surg; 2022 Feb; 48(2):252-253. PubMed ID: 34889216
[No Abstract] [Full Text] [Related]
[Next] [New Search]